Safety and feasibility of intraarterial eptifibatide as a revascularization tool in acute ischemic stroke: Clinical article

Journal of Neurosurgery

Volumn 114, Issue 4, 2011, Pages 1008-1013

  Memon, Muhammad Zeeshan ^a,b   Natarajan, Sabareesh K ^a,b   Sharma, Jitendra ^a,b   Mathews, Marlon S ^a,b   Snyder, Kenneth V ^a,b   Siddiqui, Adnan H ^a,b   Hopkins, L Nelson ^a,b   Levy, Elad I ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b Millard Fillmore Gates Circle Hospital   (United States)

Author keywords

Acute ischemic stroke; Endovascular therapy; Intraarterial eptifibatide; Revascularization

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; EPTIFIBATIDE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MALE; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OFF LABEL DRUG USE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANKIN SCALE; RECANALIZATION; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; STENT; STROKE PATIENT; SURGICAL EQUIPMENT; THROMBUS ASPIRATION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; CEREBRAL REVASCULARIZATION; ENDOVASCULAR PROCEDURES; FEASIBILITY STUDIES; FEMALE; FIBRINOLYTIC AGENTS; GRAFT OCCLUSION, VASCULAR; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INJECTIONS, INTRA-ARTERIAL; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; OFF-LABEL USE; PEPTIDES; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; SAFETY; STROKE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79953695392     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2010.8.JNS10318     Document Type: Article

References (42)

1. Abciximab Emergent Stroke Treatment Trial (AbESTT) Investigators: Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial. Stroke 36:880-890, 2005
2. Abciximab in Ischemic Stroke Investigators: Abciximab in acute ischemic stroke: a randomized, double-blind, placebo-controlled, dose-escalation study. Stroke 31:601-609, 2000
3. Adams HP Jr, Effron MB, Torner J, Dávalos A, Frayne J, Teal P, et al: Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke 39:87-99, 2008
4. Alexandrov AV, Grotta JC: Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 59:862-867, 2002
5. Antman EM, Giugliano RP, Gibson CM, McCabe CH, Coussement P, Kleiman NS, et al: Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. Circulation 99:2720-2732, 1999 (Pubitemid 29250016)
6. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al: ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 40:1366-1374, 2002
7. Deshmukh VR, Fiorella DJ, Albuquerque FC, Frey J, Flaster M, Wallace RC, et al: Intra-arterial thrombolysis for acute ischemic stroke: preliminary experience with platelet glycoprotein IIb/IIIa inhibitors as adjunctive therapy. Neurosurgery 56:46-55, 2005
8. Eckert B, Koch C, Thomalla G, Kucinski T, Grzyska U, Roether J, et al: Aggressive therapy with intravenous abciximab and intra-arterial rtPA and additional PTA/stenting improves clinical outcome in acute vertebrobasilar occlusion: combined local fibrinolysis and intravenous abciximab in acute vertebrobasilar stroke treatment (FAST): results of a multicenter study. Stroke 36:1160-1165, 2005 (Pubitemid 40798732)
9. ESPRIT Investigators: Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy: Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial. Lancet 356:2037-2044, 2000 (Erratum in Lancet 357:1370, 2001)
10. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators: A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med 337: 1118-1123, 1997
11. Goa KL, Noble S: Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention. Drugs 57:439-462, 1999 (Pubitemid 29137486)
12. Gold HK, Yasuda T, Jang IK, Guerrero JL, Fallon JT, Leinbach RC, et al: Animal models for arterial thrombolysis and prevention of reocclusion. Erythrocyte-rich versus platelet-rich thrombus. Circulation 83 (6 Suppl):IV26-IV40, 1991
13. IMS Study Investigators: Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 35:904-911, 2004
14. Janjua N, Alkawi A, Suri MF, Qureshi AI: Impact of arterial reocclusion and distal fragmentation during thrombolysis among patients with acute ischemic stroke. AJNR Am J Neuroradiol 29:253-258, 2008 (Pubitemid 351287876)
15. Kase CS, Furlan AJ, Wechsler LR, Higashida RT, Rowley HA, Hart RG, et al: Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology 57:1603-1610, 2001 (Pubitemid 33055477)
16. Kawano K, Aoki I, Aoki N, Homori M, Maki A, Hioki Y, et al: Human platelet activation by thrombolytic agents: effects of tissue-type plasminogen activator and urokinase on platelet surface P-selectin expression. Am Heart J 135:268-271, 1998 (Pubitemid 28139167)
17. Khatri P, Wechsler LR, Broderick JP: Intracranial hemorrhage associated with revascularization therapies. Stroke 38:431-440, 2007 (Pubitemid 46188260)
18. Mangiafico S, Cellerini M, Nencini P, Gensini G, Inzitari D: Intravenous tirofiban with intra-arterial urokinase and mechanical thrombolysis in stroke: preliminary experience in 11 cases. Stroke 36:2154-2158, 2005 (Pubitemid 41429237)
19. Manoharan G, Adgey AA: Considerations in combination therapy: fibrinolytics plus glycoprotein IIb/IIIa receptor inhibitors in acute myocardial infarction. Clin Cardiol 27:381-386, 2004 (Pubitemid 38849960)
20. Murugappan S, Shankar H, Kunapuli SP: Platelet receptors for adenine nucleotides and thromboxane A2. Semin Thromb Hemost 30:411-418, 2004 (Pubitemid 39180716)
21. Nordt TK, Moser M, Kohler B, Ruef J, Peter K, Kübler W, et al: Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarction. Thromb Haemost 80:881-886, 1998 (Pubitemid 28556686)
22. Ohman EM, Kleiman NS, Gacioch G, Worley SJ, Navetta FI, Talley JD, et al: Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. Circulation 95:846-854, 1997 (Pubitemid 27091524)
23. Pancioli AM, Broderick J, Brott T, Tomsick T, Khoury J, Bean J, et al: The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial. Stroke 39:3268-3276, 2008
24. PURSUIT Trial Investigators: Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. N Engl J Med 339:436-443, 1998
25. Qureshi AI, Harris-Lane P, Kirmani JF, Janjua N, Divani AA, Mohammad YM, et al: Intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke: an open-label, dose-ranging, phase I study. Neurosurgery 59: 789-797, 2006
26. Qureshi AI, Hussein HM, Janjua N, Harris-Lane P, Ezzeddine MA: Postprocedure intravenous eptifibatide following intra-arterial reteplase in patients with acute ischemic stroke. J Neuroimaging 18:50-55, 2008
27. Qureshi AI, Luft AR, Sharma M, Guterman LR, Hopkins LN: Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part I-Pathophysiological and pharmacological features. Neurosurgery 46:1344-1359, 2000 (Pubitemid 32037667)
28. Qureshi AI, Siddiqui AM, Kim SH, Hanel RA, Xavier AR, Kirmani JF, et al: Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 25:322-328, 2004 (Pubitemid 38235318)
29. Qureshi AI, Suri MF, Ali Z, Ringer AJ, Boulos AS, Nakada MT, et al: Intraarterial reteplase and intravenous abciximab for treatment of acute ischemic stroke. A preliminary feasibility and safety study in a non-human primate model. Neuroradiology 47:845-854, 2005
30. Rha JH, Saver JL: The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 38:967-973, 2007
31. Saqqur M, Molina CA, Salam A, Siddiqui M, Ribo M, Uchino K, et al: Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study. Stroke 38:69-74, 2007 (Pubitemid 46035608)
32. Sauvageau E, Samuelson RM, Levy EI, Jeziorski AM, Mehta RA, Hopkins LN: Middle cerebral artery stenting for acute ischemic stroke after unsuccessful Merci retrieval. Neurosurgery 60:701-706, 2007 (Pubitemid 46581119)
33. Scarborough RM: Development of eptifibatide. Am Heart J 138:1093-1104, 1999
34. Seitz RJ, Meisel S, Moll M, Wittsack HJ, Junghans U, Siebler M: The effect of combined thrombolysis with rtPA and tirofiban on ischemic brain lesions. Neurology 62:2110-2112, 2004 (Pubitemid 38738234)
35. Shaltoni H, Martin-Schild S, Allison T, Khaja A, Gonzales N, Barreto A, et al: A phase I study of eptifibatide in acute ischemic stroke. Presented at the 59th Annual Meeting of the American Academy of Neurology, Boston, 2007 (Poster) (http:// www.abstracts2view.com/aan2007boston/view.php?nu= AAN07L-IN3-2.009) [Accessed September 2, 2010]
36. Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS, et al: Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 39: 1205-1212, 2008 (Pubitemid 351440692)
37. Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP, et al: Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 36: 1432-1438, 2005 (Pubitemid 40967507)
38. Straub S, Junghans U, Jovanovic V, Wittsack HJ, Seitz RJ, Siebler M: Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in acute middle cerebral artery occlusion. Stroke 35:705-709, 2004 (Pubitemid 38280845)
39. Szabo S, Walter T, Etzel D, Ehlers R, Kazmaier S, Beyer ME, et al: Benefical effects of reteplase in combination with abciximab: platelet/leukocyte interactions and coagulation system. Int J Clin Pharmacol Res 23:37-40, 2003 (Pubitemid 38282332)
40. TIMI Study Group: The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 312:932-936, 1985
41. Yasuda T, Gold HK, Fallon JT, Leinbach RC, Garabedian HD, Guerrero JL, et al: A canine model of coronary artery thrombosis with superimposed high grade stenosis for the investigation of rethrombosis after thrombolysis. J Am Coll Cardiol 13:1409-1414, 1989 (Pubitemid 19114215)
42. Yasuda T, Gold HK, Leinbach RC, Saito T, Guerrero JL, Jang IK, et al: Lysis of plasminogen activator-resistant platelet-rich coronary artery thrombus with combined bolus injection of recombinant tissue-type plasminogen activator and antiplatelet GPIIb/IIIa antibody. J Am Coll Cardiol 16:1728-1735, 1990